news

« BACK

Health



Results 1 - 20 of 107.
1 2 3 4 5 6 Next »


Health - Career - 07.04.2021
Increased risk of Covid-19 in precarious but essential work situations
Researchers evaluate relationship between pandemic and occupational health Wednesday, April 7, 2021 — Commissioned by the ETUI, the research institute of the European Trade Union Confederation, Damini Purkayastha, Christophe Vanroelen and their colleagues at VUB's Interface Demography research group examined the relationship between occupational health and the Covid-19 pandemic.

Life Sciences - Health - 05.04.2021
International team identifies genetic link between face and brain shape
An interdisciplinary team led by KU Leuven and Stanford has identified 76 overlapping genetic locations that shape both our face and our brain. What the researchers didn't find is evidence that this genetic overlap also predicts someone's behavioural-cognitive traits or risk of conditions such as Alzheimer's disease.

Health - Pharmacology - 01.04.2021
VUB provides breakthrough in chronic pain management
Thursday, April 1, 2021 — An international team of experts has provided a breakthrough in the study of chronic pain in rheumatoid arthritis patients. “We discovered that hypersensitivity is often the cause for all kinds of chronic pain. Personalised treatment tailored to the patient offers the solution here,' says VUB professor Jo Nijs, who is in charge of the project.

Health - 30.03.2021
Experimental hearing implant succeeds in registering brain waves
Researchers at KU Leuven have succeeded for the first time in measuring brain waves directly via a cochlear implant. These brainwaves indicate in an objective way how good or bad a person's hearing is. The research results are important for the further development of smart hearing aids. A cochlear implant enables people with severe hearing loss to hear again.

Health - Pharmacology - 30.03.2021
VIB/VUB-team map immune cells in aggressive brain tumor
Human glioblastoma tumors are aggressive hard-to-treat brain cancers that have a high unmet need for new treatment options. A team of researchers led by Prof. Kiavash Movahedi and Prof. Jo Van Ginderachter (VIB-VUB), in collaboration with colleagues from VIB, VUB, and KU Leuven, have mapped the immune landscape in these glioblastoma tumors.

Computer Science - Health - 05.03.2021
Cardiology prepared for the fourth dimension
What if heart specialists could simulate the fitting of a new heart valve in 4D before an operation? 4D CT scanners add the dimension of time to three-dimensional images and visualise the movement of the heart in detail.

Social Sciences - Health - 03.03.2021
Green tea supplements modulate facial development of children with Down syndrome
Green tea supplements modulate facial development of children with Down syndrome
A new study led by Belgian and Spanish researchers published in Scientific Reports adds evidence about the potential benefits of green tea extracts in Down syndrome. The researchers observed that the intake of green tea extracts can reduce facial dysmorphology in children with Down syndrome when taken during the first three years of life.

Health - Pharmacology - 08.02.2021
Scientists switch on tissue repair in inflammatory bowel disease
A method that instructs immune system cells to help repair damaged tissues in the intestine has been developed by researchers at KU Leuven and Seoul National University. This opens the way for more effective treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease. The study was carried out on humans and mice.

Health - Social Sciences - 20.01.2021
Transport poverty is a problem for every layer of the population
Mobiel 21 and Netwerk Duurzame Mobiliteit (Network Sustainable Mobility), with researchers from the University of Ghent and the Vrije Universiteit Brussel, have investigated the underlying factors of transport poverty.

Health - Pharmacology - 13.01.2021
Mechanism that causes irritable bowel syndrome
KU Leuven researchers have identified the biological mechanism that explains why some people experience abdominal pain when they eat certain foods. The finding paves the way for more efficient treatment of irritable bowel syndrome and other food intolerances. Up to 20% of the world's population suffers from irritable bowel syndrome (IBS), which causes stomach pain or severe discomfort after eating.

Life Sciences - Health - 11.01.2021
New criteria bring stem cell research one step closer to long-sought goal
New criteria bring stem cell research one step closer to long-sought goal
Creating stem cells that can give rise to any cell type in the early embryo and its supporting structures, including the placenta: some call it 'the holy grail' of stem cell research. An international team of researchers offer new criteria to determine whether a mouse stem cell line has this much-wanted ability, known as totipotency.

Health - Life Sciences - 22.12.2020
Our 10 most-read science news stories of 2020
From stars in another galaxy to a microscopic virus that has taken hold of the entire Earth: in this overview we present the most-read news items about research at KU Leuven in 2020. Bioscience engineers and economists from KU Leuven mapped out how wood could replace petroleum in the chemical industry.

Health - Pharmacology - 01.12.2020
Update: KU Leuven Covid-19 vaccine study published in Nature
Update: KU Leuven Covid-19 vaccine study published in Nature
Today, virologists at the KU Leuven Rega Institute published the results of their pre-clinical study into a Covid-19 vaccine candidate in  Nature . Their paper builds on a preprint that the team shared on bioRxiv earlier this year, and that  we reported on. The vaccine candidate is based on the yellow fever vaccine and thus also protects against yellow fever.

Research Management - Health - 18.11.2020
25 Ghent University researchers are ’Highly Cited Researcher 2020’
This year, Ghent University has no less than 25 researchers with Highly Cited status. This is another fine recognition of the quality of its publications and their scientific impact.

Health - Life Sciences - 17.11.2020
Existing antidepressant helps to inhibit growth of cancer cells in lab animals
New research has shown that the antidepressant sertraline helps to inhibit the growth of cancer cells. The substance acts on a metabolic addiction that allows different types of cancer to grow. This is shown by a study on cell cultures and lab animals performed by various research labs of KU Leuven.

Health - Pharmacology - 26.10.2020
’Preventive malaria treatment improves children’s performance at school’
UAntwerp involved in large-scale international research to be published in The Lancet. School-aged children who are given anti-malaria drugs preventively are only half as likely to catch the disease. And that's not all: their risk of anaemia decreases by 15%, and their school performance improves. All this has been demonstrated by international research in which the University of Antwerp was also involved.

Health - Pharmacology - 09.10.2020
Hydroxychloroquine does not counter SARS-CoV-2 in hamsters, but a high dose of favipiravir does
Hydroxychloroquine does not counter SARS-CoV-2 in hamsters, but a high dose of favipiravir does
Virologists at the Rega Institute have shown that the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters. A high dose of the anti-flu drug favipiravir, by contrast, has an antiviral effect in the hamsters.

Health - Life Sciences - 06.10.2020
Targeting our second brain to fight diabetes
In brief: Patrice Cani (UCLouvain) and Claude Knauf (INSERM) have discovered a 'jammer' that blocks communication between the gut and the brain, thus preventing proper regulation of sugar and causing insulin resistance in people with diabetes They also discovered that a lipid produced by our body helps prevent this dysfunction and regulate sugar level, thus mitigating diabetes and intestinal inflammation.

Health - 06.10.2020
New study sheds light on COVID-19 outcomes in patients with rare inborn immune disorders
An international consortium led by Isabelle Meyts (KU Leuven) and Stuart Tangye (Garvan Institute) has published its findings on COVID-19 outcomes in individuals with rare inherited immune disorders known as PIDs. Compared to the general population, these patients had similar disease outcomes, but they were more likely to need intensive care and their average age was lower.

Health - 25.09.2020
Cause of mysterious nodding disease
River blindness is the root cause, and nodding disease can easily be controlled by administering an anti-parasitic drug and exterminating the blackfly. For several years now, researchers from the University of Antwerp have been collaborating with African scientists to investigate the causes of 'nodding disease', a mysterious form of epilepsy that only affects children on the African continent.
1 2 3 4 5 6 Next »

This site uses cookies and analysis tools to improve the usability of the site. More information. |